Collplant Biotechnologies
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $4 | $249 | $98 | $299 |
Gross Profit | -268 | -287 | -727 | -474 |
EBITDA | -4,287 | -4,145 | -4,049 | |
EBIT | -4,542 | -4,406 | -4,329 | |
Net Income | -4,326 | -4,210 | -4,195 | -4,689 |
Net Change In Cash | 4 | 249 | 98 | 299 |
Free Cash Flow | -3,588 | -4,130 | -3,335 | -2,574 |
Cash | 15,371 | 18,920 | 23,464 | 26,674 |
Basic Shares | 11,454 | 11,454 | 11,453 | 11,452 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $10,959 | $299 | $15,641 | $6,137 |
Gross Profit | 8,968 | -101 | 13,636 | 3,135 |
EBITDA | -6,410 | -16,021 | 838 | -4,939 |
EBIT | -7,512 | -17,097 | 65 | -5,599 |
Net Income | -7,019 | -16,753 | 409 | -5,808 |
Net Change In Cash | 10,959 | 299 | 15,641 | 6,137 |
Free Cash Flow | -3,717 | -15,014 | 912 | -4,970 |
Cash | 26,674 | 29,653 | 13,148 | 3,333 |
Basic Shares | 11,389 | 11,033 | 11,966 | 6,886 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.37 |
2024-03-31 | -$0.37 |
2023-12-31 | -$0.24 |
